WallStreetZenWallStreetZen

NASDAQ: GH
Guardant Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for GH

Based on 6 analysts offering 12 month price targets for Guardant Health Inc.
Min Forecast
$27.00+55.71%
Avg Forecast
$37.50+116.26%
Max Forecast
$50.00+188.35%

Should I buy or sell GH stock?

Based on 6 analysts offering ratings for Guardant Health Inc.
Strong Buy
Strong Buy
5 analysts 83.33%
Buy
1 analysts 16.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GH stock forecasts and price targets.

GH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-15
lockedlocked$00.00+00.00%2024-02-26
lockedlocked$00.00+00.00%2024-02-23
lockedlocked$00.00+00.00%2024-02-23
lockedlocked$00.00+00.00%2023-11-13
Morgan Stanley
Bottom 11%
11
Strong BuyMaintains$50.00+188.35%2023-11-08

1 of 1

Forecast return on equity

Is GH forecast to generate an efficient return?
Company
N/A
Industry
0.02%
Market
19.68%

Forecast return on assets

Is GH forecast to generate an efficient return on assets?
Company
N/A
Industry
0.02%

GH revenue forecast

What is GH's revenue in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$664.4M+17.81%
Avg 2 year Forecast
$802.2M+42.25%
Avg 3 year Forecast
$1.0B+84.02%
GH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GH revenue growth forecast

How is GH forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
21.15%
Industry
6%
Market
9.3%
GH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GH vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
GH$17.34$37.50+116.26%Strong Buy
TWST$31.50$42.67+35.45%Strong Buy
NEO$14.16$20.00+41.24%Strong Buy
MYGN$18.60$22.00+18.28%Buy
NEOG$12.31$17.00+38.10%Hold
View Top Diagnostic & Research Stocks

Guardant Health Stock Forecast FAQ

Is Guardant Health Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: GH) stock is to Strong Buy GH stock.

Out of 6 analysts, 5 (83.33%) are recommending GH as a Strong Buy, 1 (16.67%) are recommending GH as a Buy, 0 (0%) are recommending GH as a Hold, 0 (0%) are recommending GH as a Sell, and 0 (0%) are recommending GH as a Strong Sell.

If you're new to stock investing, here's how to buy Guardant Health stock.

What is GH's revenue growth forecast for 2024-2026?

(NASDAQ: GH) Guardant Health's forecast annual revenue growth rate of 21.15% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.3%.

Guardant Health's revenue in 2024 is $563,948,000.On average, 8 Wall Street analysts forecast GH's revenue for 2024 to be $80,862,525,869, with the lowest GH revenue forecast at $80,160,000,026, and the highest GH revenue forecast at $81,357,409,805. On average, 8 Wall Street analysts forecast GH's revenue for 2025 to be $97,642,693,989, with the lowest GH revenue forecast at $96,396,477,408, and the highest GH revenue forecast at $99,475,687,612.

In 2026, GH is forecast to generate $126,310,787,287 in revenue, with the lowest revenue forecast at $115,529,717,621 and the highest revenue forecast at $135,887,874,688.

What is GH's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: GH) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 0.02%.

What is GH's Price Target?

According to 6 Wall Street analysts that have issued a 1 year GH price target, the average GH price target is $37.50, with the highest GH stock price forecast at $50.00 and the lowest GH stock price forecast at $27.00.

On average, Wall Street analysts predict that Guardant Health's share price could reach $37.50 by Apr 15, 2025. The average Guardant Health stock price prediction forecasts a potential upside of 116.26% from the current GH share price of $17.34.

What is GH's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: GH) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.